Press Releases
Gallego at Crooked Con: Talk About What Matters, Affordability
WASHINGTON – At Crooked Con today, Senator Ruben Gallego (D-AZ) spoke about how Democrats can win back working-class voters by focusing the party’s message on issues that matter, and rebuilding trust by showing up everywhere and talking to everyone. In a conversation with Crooked co-founder and former presidential speechwriter Jon Lovett, Senator Gallego spoke on how Democrats can connect with voters, win on affordability, and build a bigger tent party. Read excerpts of their conversation below: On winning voters by talking about what matters: affordability “When Democrats are talking about voters – and this is a thing that I did, I was really different from other people
Gallego Backs Bipartisan Legislation to Support Veterans’ Mental Health
WASHINGTON – Senator Ruben Gallego (D-AZ) backed bipartisan legislation to better support the mental health needs of veterans and servicemembers as they return home. The Daniel J. Harvey Jr. and Adam Lambert Improving Servicemember Transition to Reduce Veteran Suicide Act would improve the Department of Defense’s Transition Assistance Program (TAP) and the Department of Veterans Affairs’ (VA) Solid Start program by providing increased mental health support for transitioning servicemembers and veterans. The bill was named in memory of two Marines who lost their lives to suicide: Lance Cpl. Daniel J. Harvey, Jr., of Rhode Island, and Cpl. Adam Lambert of Iowa. “When I got back from Iraq,
Gallego, Senate Dems Demand Answers on Trump Admin’s New “Review” of Mifepristone
“We are seriously alarmed by this administration’s obvious attempts to interfere with the science and politicize the drug review process in order to restrict abortion access.” WASHINGTON — Today, Senator Ruben Gallego (D-AZ) joined the entire Senate Democratic caucus in writing to U.S. Department of Health and Human Services (HHS) Secretary Kennedy and U.S. Food and Drug Administration (FDA) Commissioner Makary expressing alarm over the Trump administration’s plans to conduct “its own review of the evidence” on the safety and effectiveness of mifepristone. Mifepristone was approved by the FDA in 2000 and is used in the overwhelming majority of abortions in the United States. Access to medication